MedPath

Evaluation of ultrasonic whole-mouth instrumentation in the treatment of Chronic Periodontitis in diabetic patients

Not Applicable
Conditions
Periapical granuloma
C07.320.830.700.740
Registration Number
RBR-9792k8
Lead Sponsor
Escola Bahiana de Medicina e Saúde Pública
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Presented severe chronic periodontitis verified by the presence of periodontal pockets, loss of insertion and radiographic bone loss; presence of at least 8 teeth with probing depth greater than or equal to 5 mm and bleeding at probing, of these at least 2 teeth should have a depth of probing greater than or equal to 6 mm and 2 more with depth of probing greater than or equal to 7 mm; decompensated diabetics, glycated hemoglobin value greater than or equal to 7%; minimum of 15 teeth, excluding third molars

Exclusion Criteria

Periapical or pulp alterations on qualifying teeth, consumption of drugs known to affect periodontal status (antibiotic, anti-inflammatory, anticonvulsant, immunosuppressant, or calcium channel blocker) within the past 3 months, periodontal treatment, including subgingival scaling and root planning in the preceding 6 months, systemic and immunological disorders other than diabetes that require prophylactic antibiotic coverage or that could influence response to treatment, smoking, pregnancy and cardiac pace-makers users

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ltrasonic all-mouth debridement proved to be as effective as the conventional scaling and root planing treatment for the improvement of severe chronic periodontitis in decompensated diabetic patients, ascertained from the evaluation of clinical periodontal parameters of depth of depth, clinical insertion level and position of the gingival margin, one and three months after the intervention. The Friedman and Mann-Whitney statistical tests were used, with significance level less than or equal to 5%;The percentage of sites that needed re-treatment at 3 months, and the results were similar between test (18.7%) and control (19.8%) groups (p=0.702). The analysis of the percentage of sites that had an increase of clinical level insertion of 2 mm revealed that the test group had better results at one and three months of follow-up than the control group, and this difference was statistically significant (p=0.0001) and (p=0,028)
Secondary Outcome Measures
NameTimeMethod
The analysis of glycated haemoglobin and fasting plasma glucose results revealed that there were no statistically significant differences between groups or between time points
© Copyright 2025. All Rights Reserved by MedPath